Varibar Thin Liquid Gets FDA Approval for Modified Barium Swallow Studies

The Food and Drug Administration (FDA) has approved Varibar Thin Liquid for oral suspension (barium sulfate; Bracco Diagnostics Inc.) for use in modified barium swallow (MBS) examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients.

Varibar Thin Liquid is a radiographic contrast agent that is supplied as a powder for suspension for oral administration containing 120g of barium sulfate (81% w/w). It must be reconstituted with water prior to administration by a healthcare professional. During a single MBS examination, multiple doses of Varibar Thin Liquid may be administered to assess the patient during multiple swallows and different radiographic views.

“FDA has now granted approval to the entire line of the Varibar imaging agents. This means that all Varibar products meet the safety, efficacy and quality standards of the FDA,” said Alberto Spinazzi, MD, Senior Vice President, Chief Medical and Regulatory Officer, Bracco Group. “We are proud of the fact that Varibar products are the only imaging agents approved for use in MBS studies.”

The Varibar product line also includes Varibar Honey, Varibar Thin Honey, Varibar Nectar, and Varibar Pudding.

For more information visit braccoimaging.com.